NovaBay Pharmaceuticals, Inc. ( NBY) - Key Metrics
Stock symbol NBY is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker NBY was renamed to
SDEV
effective 2026-04-06.
NBY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | -$0.33 | -$0.51 | -$0.51 |
| 2025Q1 | ? | $1.44 | -$0.25 | -$0.25 |
| 2024Q4 | $0.47 | -$0.25 | -$0.20 | -$0.20 |
NBY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -0.44 |
| 2025Q1 | ? | 0.10 |
| 2024Q4 | ? | -0.61 |
NBY
Price: $1.88
52 week price:
Earnings Per Share: -28.50 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 100900
Market Capitalization: 51.9 million